Lipitor Lawsuit Hearing Rescheduled for February after Winter Weather Postponement, Bernstein Liebhard LLP Reports
The attorneys at Bernstein Liebhard LLP are investigating claims by potential Lipitor lawsuit claimants who may have developed Type 2 diabetes after taking the cholesterol-lowering statin.
New York, NY (PRWEB) February 02, 2014
Plaintiffs in Lipitor lawsuits (http://www.thelipitorlawsuit.com/) continue to wait for a federal Panel’s decision on whether to consolidate cases over the cholesterol drug after inclement weather caused last week’s hearing on the matter to be postponed, Bernstein Liebhard LLP reports.
The U.S. Judicial Panel on Multidistrict Litigation (JPML) was scheduled to hear oral arguments over the creation of a centralized Lipitor diabetes lawsuit proceeding on January 30th in New Orleans, before weather complications caused by Winter Storm Leon resulted in a barrage of flight cancellations and other transportation issues to the Louisiana city. The hearing has since been rescheduled for February 6, 2014 at 9:00 a.m. Among the items listed on this meeting’s agenda will be a discussion of lawsuits filed on behalf of women who allegedly developed Type 2 diabetes after taking the statin, court records indicate. (In re Lipitor (Atorvastatin) Litigation, MDL No. 2502 (JPML))
“As we continue to hear from individuals who may have been injured by Lipitor, our Firm awaits the rescheduled date of this court hearing. The number of Lipitor lawsuits in federal court has grown substantially over the past few months, making the Panel’s upcoming decision over whether to centralize the cases that much moretimely,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective medical devices and drugs including Lipitor. The Firm is currently offering free and confidential Lipitor lawsuits to plaintiffs who may have been injured by the medication.
Court documents show that more than 100 Lipitor lawsuits against the drug’s manufacturer, Pfizer Inc. have been filed in the U.S, and that the JPML’s upcoming hearing will be the second time oral arguments regarding the consolidation of cases will have been heard. The first was in April 2013, when plaintiffs’ request for a multidistrict litigation was rejected by the Panel on the grounds that only about a dozen Lipitor-related cases had been filed, which was not enough to warrant one.
Although no decision has been made on the creation of a Lipitor lawsuit litigation, a number of claims are currently pending in two U.S. federal courts. In October 2013, a federal judge ordered that all cases filed in the U.S. District Court for the Southern District of Illinois be coordinated in that jurisdiction, and all claims pending in the U.S. District Court, District of South Carolina remain there for pretrial purposes. At the time, the Order indicated that 14 cases were being informally coordinated in the South Carolina court. (Hines v.Pfizer Inc., No. 13-404)
Lipitor lawsuits allege that Pfizer Inc. failed to adequately warn patients and their doctors about the cholesterol drug’s potential to cause new-onset Type 2 diabetes, and that the U.S. Food and Drug Administration(FDA) ’s February 2012 mandate to include the risk on its labeling is insufficient.
The federal agency’s order to note Lipitor’s association with diabetes was issued after the findings of a study published in JAMA: Internal Medicine found that post-menopausal women treated with the statin may be more likely to develop the disease.*
Individuals who allegedly developed new-onset Type 2 diabetes after taking Lipitor may be entitled to compensation for out-of-pocket medical bills, lost wages, pain and suffering and other damages. Learn more about filing a Lipitor lawsuit at Bernstein Liebhard LLP’s website, or call 800-511-5092 to arrange for a free legal review.
*archinte.jamanetwork.com/article.aspx?articleid=1108676, JAMA Internal Medicine, January 2012
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the top plaintiffs firms in the country, for the past 11 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com
For the original version on PRWeb visit: http://www.prweb.com/releases/lipitor-lawsuit/lipitor-diabetes/prweb11544689.htm